MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Allakos (Nasdaq: ALLK) for possible breaches of fiduciary duty and other violations of law in its transaction with Concentra.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Dada Nexus Limited (NASDAQ: DADA) to JD Sunflower Investment Limited for $2.00 per ...

— We have everything you need: full data on over 800 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & ...

Today, a brief rundown of news involving Sarepta Therapeutics, Novartis and Allakos, as well as updates from CSL Behring and Roche that you may have missed. Novartis’s deal for Regulus is its second ...

SAN CARLOS, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (“Allakos”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory ...

We are headquartered at the Empire State Building in New York City and are investigating Allakos Inc. (NASDAQ: ALLK), relating to the proposed merger with Concentra Biosciences, LLC.

SAN CARLOS, Calif. - Allakos Inc. (NASDAQ:ALLK), a biotechnology firm focused on developing antibodies to treat allergic and inflammatory diseases, has announced a definitive merger agreement with ...